Press Resease

Endocrine Testing Market - Global Industry Analysis

Endocrine Testing Market By Tests (Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH),Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), Testosterone, Thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and Other Test), By Technology (Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Sensors, Clinical Chemistry Technologies, and Others), By End-user (Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals, and Other Healthcare Settings): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 08-Jun-2021 Category: Medical Device Report Format : PDF Pages: 120 Report Code: ZMR-385 Status : Published

The global Endocrine Testing market accounted for USD 8.4 Billion in 2020 and is expected to reach USD 16.6 Billion by 2028, growing at a CAGR of 8.9% from 2021 to 2028.

Description

Market Overview    

The global Endocrine Testing market accounted for USD 8.4 Billion in 2020 and is expected to reach USD 16.6 Billion by 2028, growing at a CAGR of 8.9% from 2021 to 2028.    

The endocrine system is a setup of glands that produce and discharge hormones which aid control several vital body utilities, inclusive of the body's capability to alteration of calories into energy which commands organs and cells. The endocrine system impacts the way our heart beats, growth of bones and tissues, also the ability to make a kid. It plays a key role in developing diabetes, growth disorders, sexual dysTest, thyroid disease and a multitude of additional hormone-related disorders.

Key players in the industry are developing advanced testing devices for the end-users at a competitive price point. Major collaborations, technologically enhanced products and regulatory approvals are other factors stimulating the market.

COVID-19 Impact Analysis:

The restrictions imposed by various nations to contain COVID had stopped the demand and supply resulting in a disruption across the whole supply chain. However, the global markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year.  The significant decrease in the Global Endocrine Test market End-user in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.  

Growth Factors

Mounting health awareness, early endocrine disorder diagnosis, and favorable government policies is predicted to inflate the growth of endocrine testing market over the ensuing years. Apart from this, exponential increase in diabetes patients and elderly & obese population is forecast to augment the endocrine testing market End-user over the forthcoming years.

Soaring technology costs, however, is projected to inhibit the progression of endocrine testing market over the next few years. Nevertheless, massive funding of R&D activities and technological innovations are expected to open new growth opportunities for the business, thereby normalizing the impact of hindrances on the endocrine testing market.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview  

Endocrine Testing market is segmented into Dehydroepiandrosterone sulfate (DHEAS),  Progesterone, Luteinizing Hormone (LH), Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), Testosterone, Thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin and Other Test. Thyroid Stimulating Hormone (TSH) is anticipated to grow owing to increasing thyroid related disorders across the globe.

On the basis of technology the market is segmented into Monoclonal & Polyclonal Antibody Technologies, Tandem Mass Spectrometry, Immunoassay, Sensors, Clinical Chemistry Technologies, and Others. Clinical Chemistry Technologies segmented is projected to grow owing to major technical advancement coupled with enhanced diagnostics demand.

On the basis of End-user Endocrine Testing is segmented into Commercial Laboratories, Home-Based Tests, Ambulatory Care Centers, Hospitals, and Other Healthcare Settings. Hospital segment is anticipated to grow owing to increasing demand of health facilities across the globe.

North America region hold the major share in the market and is likely to remain dominant throughout the forecast period. This is due to the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market.

Key Market Players & Competitive Landscape

The major players operating in the Endocrine Testing market are Bio Rad Laboratories, DIASORIN, Hoffmann-La Roche Ltd., LabCorp, Quest Diagnostics,  Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, and  bioMerieux SA, among others.

The global Endocrine Testing market is segmented as follows:   

By Tests

  • Dehydroepiandrosterone sulfate (DHEAS)
  • Progesterone
  • Luteinizing Hormone (LH)
  • Estradiol (E2)
  • Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH)
  • Testosterone
  • Thyroid prolactin
  • Thyroid Stimulating Hormone (TSH), cortisol, insulin
  • Other Test

By Technology

  • Monoclonal & Polyclonal Antibody Technologies
  • Tandem Mass Spectrometry
  • Immunoassay
  • Sensors
  • Clinical Chemistry Technologies
  • Others

By End-user

  • Commercial Laboratories
  • Home-Based Tests
  • Ambulatory Care Centers
  • Hospitals
  • Other Healthcare Settings

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Tests
        • 2.1.1.2. Market Attractiveness Analysis, By Technulogy
        • 2.1.1.3. Market Attractiveness Analysis, By End-user
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Endocrine Testing Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Endocrine Testing Market – Tests Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Tests, 2020 & 2028
    • 4.2. Dehydroepiandrosterone sulfate (DHEAS)
      • 4.2.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Progesterone
      • 4.3.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Luteinizing Hormone (LH)
      • 4.4.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Estradiul (E2)
      • 4.5.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Human Chorionic Gonadotropin (hCG), Fullicle Stimulating (FSH)
      • 4.6.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Testosterone
      • 4.7.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.8. Thyroid prulactin
      • 4.8.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.9. Thyroid Stimulating Hormone (TSH), cortisul, insulin
      • 4.9.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.10. Other Test
      • 4.10.1. Market End-user and Forecast, By Region (USD Billion)
      • 4.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.10.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5: Endocrine Testing Market – Technulogy Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Technulogy, 2020 & 2028
    • 5.2. Monoclonal & Pulyclonal Antibody Technulogies
      • 5.2.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Tandem Mass Spectrometry
      • 5.3.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Immunoassay
      • 5.4.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Sensors
      • 5.5.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Clinical Chemistry Technulogies
      • 5.6.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Others
      • 5.7.1. Market End-user and Forecast, By Region (USD Billion)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Endocrine Testing Market – End-user Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By End-user, 2020 & 2028
    • 6.2. Commercial Laboratories
      • 6.2.1. Market End-user and Forecast, By Region (USD Billion)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Home-Based Tests
      • 6.3.1. Market End-user and Forecast, By Region (USD Billion)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Ambulatory Care Centers
      • 6.4.1. Market End-user and Forecast, By Region (USD Billion)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Hospitals
      • 6.4.1. Market End-user and Forecast, By Region (USD Billion)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.6. Other Healthcare Settings
      • 6.6.1. Market End-user and Forecast, By Region (USD Billion)
      • 6.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Endocrine Testing Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.2.2. North America Market Revenue, By Test, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Technulogy, 2016 – 2028
      • 7.2.4. North America Market Revenue, By End-user, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Test, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Technulogy, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By End-user, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Test, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Technulogy, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By End-user, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Test, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Technulogy, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By End-user, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.3.2. Europe Market Revenue, By Test, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Technulogy, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By End-user, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Test, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Technulogy, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By End-user, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Test, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Technulogy, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By End-user, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Test, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Technulogy, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By End-user, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Test, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Technulogy, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By End-user, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Test, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Technulogy, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By End-user, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Test, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Technulogy, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By End-user, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.4.2. Asia Pacific Market Revenue, By Test, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Technulogy, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By End-user, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Test, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Technulogy, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By End-user, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Test, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Technulogy, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By End-user, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Test, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Technulogy, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By End-user, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Test, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Technulogy, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By End-user, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Test, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Technulogy, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By End-user, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Test, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Technulogy, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By End-user, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.5.2. Latin America Market Revenue, By Test, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Technulogy, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By End-user, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Test, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Technulogy, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By End-user, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Test, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Technulogy, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By End-user, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Test, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Technulogy, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By End-user, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Test, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Technulogy, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By End-user, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Test, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Technulogy, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By End-user, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Test, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Technulogy, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By End-user, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Test, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Technulogy, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By End-user, 2016 – 2028
  • Chapter No. 8 Endocrine Testing Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Tests Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Endocrine Testing Market: Company Market Share, 2019
      • 9.1.2. Global Endocrine Testing Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 9.1.3. Global Endocrine Testing Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Endocrine Testing Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10: Company Profiles
    • 10.1. Bio Rad Laboratories
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfulio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. DIASORIN
    • 10.3. Hoffmann-La Roche Ltd.
    • 10.4. LabCorp
    • 10.5. Quest Diagnostics
    • 10.6. Abbott Laboratories
    • 10.7. AB Sciex
    • 10.8. Agilent Technulogies
    • 10.9. Biomedical Technulogies
    • 10.10. bioMerieux SA
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Technulogy Change
  • Chapter No. 12 Research Methodulogy
    • 12.1. Research Methodulogy
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Endocrine Testing market. Zion Research has collected and analyzed key data belong to the global Endocrine Testing market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Endocrine Testing across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Endocrine Testing industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Endocrine Testing market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

The endocrine system is a very complex network that consists of several glands located throughout the body. Endocrine diagnostics test to measure the level of various hormones in a human body. It is also used to identify whether the endocrine glands are working properly. An optimally functioning endocrine system is essential to restoring and maintaining health.

Globally, the endocrine testing market has been accelerated on account of the rapid growth global geriatric population in both developed and developing countries. The changing lifestyles, increasing stress, and unhealthy food habits result in increased obesity and disturbed hormonal changes, which contributed substantially towards the growth of the endocrine diagnostics market. Moreover, increasing health awareness coupled with the government initiatives facilitated early diagnosis of endocrine disorders, which is expected to propel the demand for endocrine test kits. However, the high cost of technology is expected to be the major restraint for the growth of the endocrine testing market. Nonetheless, investment in research and technology is considered as a major opportunity for the growth of the global endocrine testing market.

Global Endocrine Testing Market

The endocrine testing market can be segmented on the basis of test such as Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests such as gastrin, thymosin, and secretin tests. Thyroid stimulating hormone (TSH) was the leading segment owing to rising incidences of thyroid disorders and the growing awareness about the correlation between variations in the thyroid hormones levels and cardiovascular disorders. Insulin test is expected to witness the fastest growth in the years to come. This growth is mainly due to increase the rate of diabetes patients across the globe.

On the basis of technology, the market can be segmented into monoclonal & polyclonal antibody technologies, tandem mass spectrometry, immunoassay, sensors, clinical chemistry technologies, and others. Tandem mass spectrometry is expected to show significant growth in the years to come. Mass spectroscopy analysis is the most recent developed technology. The sensitivity of the tests by mass spectroscopy technology is very high.

Some of the key end-users include commercial laboratories, home-based tests, ambulatory care centers, hospitals and other healthcare settings. The commercial laboratories were the largest segment due to advanced infrastructure coupled with skilled personnel. The home-based test segment is growing fast with the introduction of new user-friendly and cost-effective diagnostic kits. This is expected to increase the penetration of home-based tests.

North America is projected to be the largest revenue contributing region. North America is expected to remain the dominant region over the next few years. Asia-Pacific is projected to be the fastest-growing region in the endocrine testing market during the forecast period as a result of demand from developing economies such as China and India. As a result of increasing aging population and increasing health awareness in Brazil, Latin America is also expected to experience significant growth in the years to come.

Some of the key players operating into this market include Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies and bioMerieux SA.


Frequently Asked Questions

The global Endocrine Testing market was valued at USD 8.4 Billion in 2020.

The global Endocrine Testing market is expected to reach USD 16.6 Billion by 2028, growing at a CAGR of 8.9% between 2021 to 2028.

Some of the key factors driving the global Endocrine Testing market growth are rising health issues across the globe.

North America Endocrine Testing market is expected to show strong growth on account of growing technological spending and facilities.

The major players operating in the Endocrine Testing market are Bio Rad Laboratories, DIASORIN, Hoffmann-La Roche Ltd., LabCorp, Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, and bioMerieux SA, among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social